FLOT Chemotherapy: A Thorough British Guide to the FLOT Regimen for Gastric Cancer
FLOT chemotherapy is a multimodal treatment approach used in the management of certain stomach and gastro-oesophageal cancers. The acronym FLOT stands for four chemotherapeutic agents: 5-fluorouracil (5-FU), leucovorin, oxaliplatin and docetaxel. When used together as a coordinated regimen, FLOT chemotherapy aims to shrink tumours, improve surgical outcomes and, in some cases, extend survival. This guide explains what FLOT chemotherapy involves, what to expect before, during and after treatment, potential side effects, and tips for staying well supported throughout the journey.
What is FLOT chemotherapy?
FLOT chemotherapy is a combination chemotherapy regimen designed to attack cancer cells through a multi-pronged mechanism. The four drugs work in different ways to disrupt cancer cell growth and division, making it harder for tumours to resist treatment. In many treatment pathways, FLOT chemotherapy is given before surgery (neoadjuvant therapy) to reduce tumour size and increase the chances of a successful operation. In some circumstances, it may also be used after surgery (adjuvant therapy) or as part of a wider plan tailored to an individual’s cancer profile.
The four components of FLOT
5-fluorouracil (5-FU): A bright, long-standing pillar of chemotherapy, 5-FU interferes with the cancer cell’s ability to make DNA and RNA, slowing growth. Nurses and doctors closely monitor blood counts and bowel function because this drug can affect the gut and bone marrow.
Leucovorin: Not a chemotherapy agent on its own, leucovorin enhances the activity of 5-FU. It helps the 5-FU to bind more effectively to its target in cancer cells, potentially boosting anti-tumour effects while also affecting tolerance and side effects.
Oxaliplatin: A platinum-based drug that damages cancer cell DNA and hinders cell division. Oxaliplatin can cause sensory nerve changes, such as tingling or numbness in the hands and feet, which are important to monitor during treatment.
Docetaxel: A taxane that interferes with the microtubules necessary for cell division. Docetaxel can contribute to side effects such as hair loss, fatigue, and low blood counts, but it can also play a crucial role in shrinking tumours when used alongside the other drugs in the FLOT combination.
In combination, these drugs attack cancer cells from multiple angles. The hope is to achieve greater tumour reduction, more effective surgical outcomes, and, for some patients, longer disease control. Your treating team will tailor the exact plan based on your cancer type, stage, overall health and prior treatments.
How FLOT chemotherapy is administered
Typical schedule and cycles
The standard neoadjuvant FLOT chemotherapy plan often comprises four cycles delivered at roughly two-week intervals. Each cycle is carefully coordinated to balance the anti-cancer effect with the body’s ability to recover between treatment days. A typical cycle may involve:
- Day 1: 5-FU (administered as a continuous infusion over 24 hours) plus leucovorin, oxaliplatin and docetaxel given intravenously
- Days 2–14: A rest period allowing the patient to recover from side effects
- Cycle repeats every two weeks, for a total of four cycles before planned surgery in appropriate cases
For some patients, the timing may be adjusted depending on how well the body tolerates treatment, the rhythm of a surgical plan, and any other health considerations. Your medical team will explain the exact schedule, infusion methods, and monitoring steps that apply to you.
Where treatment is given
FLOT chemotherapy is typically delivered in hospital or a cancer centre setting, by clinicians experienced in administering intensive regimens. Some patients may receive certain components via infusion as an outpatient, with close observation, while others may require a short stay around infusion times. A central venous access device (port) or needle may be used to deliver the drugs safely.
Monitoring and safety during treatment
Throughout FLOT chemotherapy, clinicians monitor blood counts, kidney and liver function, and heart health as appropriate. Regular blood tests and blood pressure checks help identify potential issues early. If side effects become troublesome, the care team may adjust the dose, postpone treatment, or provide supportive therapies to keep treatment on track.
Indications and what cancers FLOT chemotherapy treats
FLOT chemotherapy is most commonly used for gastric (stomach) cancer and cancers at the gastro-oesophageal junction (the area where the stomach and oesophagus meet). It may also be considered in select cases of oesophageal cancers or other complex upper GI cancers where a multimodal approach is advised. The decision to use FLOT chemotherapy depends on the cancer’s characteristics, the patient’s fitness for treatment, and the goals of care.
Effectiveness, outcomes and what patients can expect
What the evidence suggests
Clinical experience and studies have shown that FLOT chemotherapy can lead to meaningful tumour shrinkage and improved rates of complete or near-complete response when used before surgery for eligible gastric cancers. Patients who respond well to neoadjuvant FLOT may experience more straightforward surgical resections and may have improved long-term outcomes. Individual results vary based on tumour biology, stage, and overall health. Your oncologist will explain how FLOT chemotherapy may influence your prognosis in your specific case.
Quality of life considerations
Undergoing FLOT chemotherapy is a substantial undertaking. Many patients report periods of fatigue, nausea, and other side effects, but with proactive management and supportive care, people can maintain a reasonable quality of life. It is important to discuss concerns about appetite, sleep, energy levels, and mental well-being with the healthcare team so that a plan for nutrition, rest, and activity can be put in place.
Side effects and how to manage them
Common side effects
The FLOT chemotherapy combination can cause a range of side effects. Not everyone experiences all of them, and severity varies between individuals. Common effects include:
- Fatigue and weakness
- Nausea or vomiting, which is usually well managed with antiemetic medicines
- Loss of appetite and changes in taste
- Diarrhoea or constipation
- Mouth ulcers or taste changes
- Neuropathy or tingling/numbness in hands and feet (primarily from oxaliplatin)
- Hair thinning or hair loss
- Low blood cell counts, increasing infection risk and causing anaemia or fatigue
- Fluid retention and skin sensitivity
Preventing and addressing side effects
Preventive strategies and timely treatment can reduce the impact of side effects. Approaches may include:
- Prophylactic antiemetics to control nausea
- Careful hydration and nutrition support to maintain strength
- Regular blood tests to monitor blood counts and organ function
- Dose adjustments or treatment breaks if necessary to allow recovery
- Medications to manage neuropathy or mouth ulcers if symptoms arise
- Guidance on activity and rest to help balance energy levels
Communicating openly with the treatment team about any side effects is essential. Early reporting can prevent complications and ensure that supportive care is optimised.
Preparing for FLOT chemotherapy
Pre-treatment assessments
Before starting FLOT chemotherapy, patients typically undergo a comprehensive assessment. This may include:
- Blood tests to check kidney and liver function, blood counts, and electrolytes
- Imaging studies (such as CT scans or MRIs) to assess tumour size and spread
- Evaluation of heart and lung health where relevant
- Assessment of nutritional status and overall fitness for treatment
Healthy lifestyle factors can support treatment tolerance. Your team may offer guidance on nutrition, physical activity, smoking cessation, and sleep practices in the lead-up to FLOT chemotherapy.
What to arrange in advance
Preparing for a treatment period often requires practical planning, such as arranging transportation to and from the hospital, coordinating time off work, organising help at home, and setting up a plan for managing day-to-day tasks during cycles. Some patients choose to keep a diary of symptoms and side effects to discuss at appointments.
During FLOT chemotherapy: what to expect
Infusion day and hospital stay
On infusion days, patients typically visit the treatment centre for intravenous administration of the agents. Some drugs are given as a quick infusion, while others may require a continuous infusion or longer administration. Staff will monitor vital signs, manage any immediate reactions, and provide information about aftercare, including signs to watch for once you leave the hospital.
Travel, support and practical tips
Having a reliable support network is invaluable. Bringing a friend or family member to appointments can help with understanding the plan, remembering questions, and assisting with post-treatment care. Hydration, nutrition snacks, and comfortable clothing can make infusion days more manageable. Some patients find it helpful to plan short, gentle activities between cycles to maintain routine and mental well-being.
Nutrition, exercise and supportive care during FLOT chemotherapy
Nutrition as a cornerstone of treatment
Maintaining adequate nutrition supports energy levels, recovery, and immune function during FLOT chemotherapy. Small, frequent meals that are easy to digest, along with hydration, are commonly recommended. A dietitian can tailor advice to individual needs, including managing taste changes, mouth ulcers, and appetite fluctuations.
Physical activity and overall well-being
Gentle activity, as tolerated, can help with energy, mood, and recovery. Activities such as short walks, stretching, or light home-based exercises may be appropriate. Always consult the treatment team before starting or changing an exercise plan, especially if you have concerns about infection risk or fatigue.
Supportive medicines and therapies
Depending on side effects, clinicians may prescribe supportive therapies, including growth factors to help maintain blood counts, anti-nausea medication, mouth care products, and topical or oral agents for mouth ulcers. Vaccinations and infection prevention guidance may also form part of supportive care.
After completing FLOT chemotherapy and the path to surgery
Moving from chemotherapy to surgery
In many programmes, four cycles of FLOT chemotherapy are completed before planned surgical removal of the tumour. Success of the chemotherapy in shrinking the cancer can influence surgical options and potential margins. After finishing chemotherapy, there is typically a window for recovery before surgery, during which doctors re-evaluate the cancer through imaging and clinical assessment to determine the next steps.
Post-treatment monitoring and follow-up
Following surgery and completion of FLOT chemotherapy, regular follow-up is essential. This may involve physical examinations, blood tests, and periodic imaging to monitor for signs of recurrence. The exact schedule varies by centre and individual risk factors, but staying engaged with the care team is important for early detection of any issues.
FLOT chemotherapy versus other regimens
How FLOT compares with other approaches
Oncologists consider various regimens when planning treatment. FLOT chemotherapy is often chosen for its potential to achieve high rates of tumour response in eligible patients, especially when the aim is to optimise surgical outcomes and long-term disease control. Other regimens, such as combinations without one of the FLOT components or alternative agents, may be selected based on patient tolerance, prior therapies, comorbidities, and specific tumour biology. Your clinician will discuss the rationale for selecting FLOT chemotherapy and how it compares to alternatives in your particular case.
Local clinical practice and access considerations
Availability and protocol details can vary between hospitals and regions. Some centres may offer adjusted versions of FLOT chemotherapy or integrate it with emerging research protocols. Discuss eligibility, geography, and access with your treatment team to understand what is feasible within your care pathway.
Patient experiences: perspectives on FLOT chemotherapy
Real-world experiences and expectations
Patients commonly describe the experience of FLOT chemotherapy as challenging but manageable with support. Many highlight the importance of clear communication, symptom tracking, and timely management of side effects. While fatigue and discomfort are common, a thoughtful care plan, strong social support, and proactive symptom management often make the journey more tolerable and increase confidence in the treatment plan.
Quality of life and family considerations
Balancing treatment goals with quality of life is central to patient-centred care. Families and caregivers play a vital role, helping with meal planning, coordinating appointments, and providing emotional support. Transparent discussions with the healthcare team about personal priorities can help tailor the treatment approach to fit individual values and circumstances.
Frequently asked questions about FLOT chemotherapy
Is FLOT chemotherapy suitable for everyone?
No. Eligibility depends on cancer type, stage, overall health, and potential vulnerabilities such as kidney or liver function. Your oncologist will assess risks and benefits and discuss whether FLOT chemotherapy is the right approach for you.
How long does treatment take?
The full neoadjuvant plan typically spans several weeks, with four cycles delivered roughly every two weeks. The total time including surgery will depend on when surgery is scheduled and the recovery period afterwards.
What should I do to prepare physically?
Prioritise nutrition, hydration, adequate rest, and an active but gentle exercise routine as advised by your clinician. Clarify any medications or supplements that may interact with therapy with your medical team.
What are the most important warning signs to report?
Seek medical advice promptly for fever, sudden severe shortness of breath, chest pain, signs of dehydration, severe vomiting, uncontrolled bleeding, or signs of infection such as a persistent high temperature or increasing fatigue with pale skin. Timely reporting can prevent complications.
Final thoughts on FLOT chemotherapy and its role in treatment plans
FLOT chemotherapy represents a well-established, multi-agent strategy for addressing certain gastric and gastro-oesophageal cancers. By combining four potent drugs, it aims to shrink tumours, enhance surgical outcomes, and potentially improve long-term disease control. Every patient’s journey is unique, and decisions about FLOT chemotherapy should be made in close collaboration with a skilled oncology team who can tailor the plan to individual circumstances, monitor response, and provide robust supportive care. If you or a loved one is considering FLOT chemotherapy, ask detailed questions about the regimen, what to expect at each stage, how side effects can be managed, and what outcomes might be anticipated in your specific situation.